809
Views
50
CrossRef citations to date
0
Altmetric
Review

Recent advances and future of immunotherapy for glioblastoma

, , , , , , , , & show all
Pages 1245-1264 | Received 22 Apr 2016, Accepted 08 Jul 2016, Published online: 27 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Avtar Singh Gautam, Shivam Kumar Pandey, Vaibhav Lasure, Sachin Dubey & Rakesh Kumar Singh. (2023) Monoclonal antibodies for the management of central nervous system diseases: clinical success and future strategies. Expert Opinion on Biological Therapy 23:7, pages 603-618.
Read now
Vaishali Y. Londhe & Varada Date. (2020) Personalized neoantigen vaccines: a glimmer of hope for glioblastoma. Expert Review of Vaccines 19:5, pages 407-417.
Read now
Candice D. Carpenter, Iyad Alnahhas, Javier Gonzalez, Pierre Giglio & Vinay K. Puduvalli. (2019) Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target. Expert Review of Neurotherapeutics 19:7, pages 663-677.
Read now
Emaad Khansur, Ashish H. Shah, Kyle Lacy & Ricardo J. Komotar. (2019) Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research. Cancer Investigation 37:1, pages 1-7.
Read now
Giannis Sokratous, Stavros Polyzoidis & Keyoumars Ashkan. (2017) Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme. Human Vaccines & Immunotherapeutics 13:11, pages 2575-2582.
Read now
Mayuri Chandran, Marianela Candolfi, Diana Shah, Yohei Mineharu, Viveka Nand Yadav, Carl Koschmann, Antonela S. Asad, Pedro R. Lowenstein & Maria G. Castro. (2017) Single vs. combination immunotherapeutic strategies for glioma. Expert Opinion on Biological Therapy 17:5, pages 543-554.
Read now

Articles from other publishers (43)

Saket Jain, Eric J. Chalif & Manish K. Aghi. (2022) Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma. Frontiers in Oncology 11.
Crossref
Johan Karlsson, Kathryn M. Luly, Stephany Y. Tzeng & Jordan J. Green. (2021) Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies. Advanced Drug Delivery Reviews 179, pages 113999.
Crossref
Lynn Bitar, Ulrike Schumann, Renate König, Frauke Zipp & Mirko H. H. Schmidt. (2021) Targeting Immune Modulators in Glioma While Avoiding Autoimmune Conditions. Cancers 13:14, pages 3524.
Crossref
Ningning Zhao, Jiajie Zhang, Lili Zhao, Xiaoni Fu, Qian Zhao, Min Chao, Haiyan Cao, Yang Jiao, Yaqin Hu, Chao Chen, Liang Wang & Huijuan Wang. (2021) Long Noncoding RNA NONHSAT079852.2 Contributes to GBM Recurrence by Functioning as a ceRNA for has-mir-10401-3p to Facilitate HSPA1A Upregulation. Frontiers in Oncology 11.
Crossref
Rafael Franco. (2021) Current Issues in Molecular Biology Journal Enters a New Era. Current Issues in Molecular Biology 43:1, pages 384-388.
Crossref
Junsheng Li, Wen Wang, Jia Wang, Yong Cao, Shuo Wang & Jizong Zhao. (2021) Viral Gene Therapy for Glioblastoma Multiforme: A Promising Hope for the Current Dilemma. Frontiers in Oncology 11.
Crossref
Kaushik Banerjee, Felipe J. Núñez, Santiago Haase, Brandon L. McClellan, Syed M. Faisal, Stephen V. Carney, Jin Yu, Mahmoud S. Alghamri, Antonela S. Asad, Alejandro J. Nicola Candia, Maria Luisa Varela, Marianela Candolfi, Pedro R. Lowenstein & Maria G. Castro. (2021) Current Approaches for Glioma Gene Therapy and Virotherapy. Frontiers in Molecular Neuroscience 14.
Crossref
C. Possas, A. Antunes, A. M. Oliveira, M. Ramos, S. O. R. Schumacher & A. Homma. 2021. Bio#Futures. Bio#Futures 249 274 .
Jinyang Hu, Qungen Xiao, Minhai Dong, Dongsheng Guo, Xudong Wu & Baofeng Wang. (2020) Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis. Frontiers in Immunology 11.
Crossref
Mahendran Bhaskaran, Vishakante Gowda Devegowda, Vishal Kumar Gupta, Amruthesh Shivachar, Rohit Rajendra Bhosale, Muthuraman Arunachalam & Thirumalaraju Vaishnavi. (2020) Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme. ACS Chemical Neuroscience 11:19, pages 2962-2977.
Crossref
Sumaira Hanif, Pir Muhammad, Rose Chesworth, Fawad Ur Rehman, Rong-jun Qian, Meng Zheng & Bing-yang Shi. (2020) Nanomedicine-based immunotherapy for central nervous system disorders. Acta Pharmacologica Sinica 41:7, pages 936-953.
Crossref
Ashish H. ShahYudy LaFortuneGeorge M. IbrahimIahn CajigasMichael Ragheb, Stephanie H. ChenErnest J. Barthélemy, Ariel HenryJohn Ragheb. (2020) Endoscopic third ventriculostomy with choroid plexus cauterization for the treatment of infantile hydrocephalus in Haiti. Journal of Neurosurgery: Pediatrics 25:4, pages 411-416.
Crossref
Sanghee Kim. (2020) Sensory changes and lipoprotein ratios in patients with brain cancers during cancer‐related therapy: A prospective cross‐sectional study. Japan Journal of Nursing Science 17:2.
Crossref
Weilun Fu, Wenjing Wang, Hao Li, Yuming Jiao, Jiancong Weng, Ran Huo, Zihan Yan, Jie Wang, Hongyuan Xu, Shuo Wang, Jiangfei Wang, Dexi Chen, Yong Cao & Jizong Zhao. (2020) High Dimensional Mass Cytometry Analysis Reveals Characteristics of the Immunosuppressive Microenvironment in Diffuse Astrocytomas. Frontiers in Oncology 10.
Crossref
Mathieu Sinigaglia, Tarek Assi, Florent L. Besson, Samy Ammari, Myriam Edjlali, Whitney Feltus, Laura Rozenblum-Beddok, Binsheng Zhao, Lawrence H. Schwartz, Fatima-Zohra Mokrane & Laurent Dercle. (2019) Imaging-guided precision medicine in glioblastoma patients treated with immune checkpoint modulators: research trend and future directions in the field of imaging biomarkers and artificial intelligence. EJNMMI Research 9:1.
Crossref
Chia-Chi Liu, Ching-Fang Yu, Shu-Chi Wang, Hsueh-Yin Li, Chiu-Min Lin, Hsia-Han Wang, Carmen Abate & Chi-Shiun Chiang. (2019) Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor. BMC Cancer 19:1.
Crossref
Ramesh Duwa, Fakhrossadat Emami, Sooyeun Lee, Jee-Heon Jeong & Simmyung Yook. (2019) Polymeric and lipid-based drug delivery systems for treatment of glioblastoma multiforme. Journal of Industrial and Engineering Chemistry 79, pages 261-273.
Crossref
Bracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, Yael Haimovich, Gleb Slobodin, Itzhak Rosner, Carlos López-Larrea, Norbert Hilf, Sabrina Kuttruff, Colette Song, Cedrik Britten, John Castle, Sebastian Kreiter, Katrin Frenzel, Marcos Tatagiba, Ghazaleh Tabatabai, Pierre-Yves Dietrich, Valérie Dutoit, Wolfgang Wick, Michael Platten, Frank Winkler, Andreas von Deimling, Judith Kroep, Juan Sahuquillo, Francisco Martinez-Ricarte, Jordi Rodon, Ulrik Lassen, Christian Ottensmeier, Sjoerd H. van der Burg, Per Thor Straten, Hans Skovgaard Poulsen, Berta Ponsati, Hideho Okada, Hans-Georg Rammensee, Ugur Sahin, Harpreet Singh & Arie Admon. (2019) Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. Molecular & Cellular Proteomics 18:6, pages 1255-1268.
Crossref
Huixiao Dong, Wei Cao & Jian Xue. (2019) Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1. Biochemical and Biophysical Research Communications 508:4, pages 1074-1081.
Crossref
Yu Tian, Gujie Mi, Qian Chen, Birendra Chaurasiya, Yanan Li, Di Shi, Yong Zhang, Thomas J. Webster, Chunmeng Sun & Yan Shen. (2018) Acid-Induced Activated Cell-Penetrating Peptide-Modified Cholesterol-Conjugated Polyoxyethylene Sorbitol Oleate Mixed Micelles for pH-Triggered Drug Release and Efficient Brain Tumor Targeting Based on a Charge Reversal Mechanism. ACS Applied Materials & Interfaces 10:50, pages 43411-43428.
Crossref
Malak Abedalthagafi, Duna Barakeh & Kara M. Foshay. (2018) Immunogenetics of glioblastoma: the future of personalized patient management. npj Precision Oncology 2:1.
Crossref
Bracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, Yael Haimovich, Gleb Slobodin, Itzhak Rosner, Carlos López-Larrea, Norbert Hilf, Sabrina Kuttruff, Colette Song, Cedrik Britten, John Castle, Sebastian Kreiter, Katrin Frenzel, Marcos Tatagiba, Ghazaleh Tabatabai, Pierre-Yves Dietrich, Valérie Dutoit, Wolfgang Wick, Michael Platten, Frank Winkler, Andreas von Deimling, Judith Kroep, Juan Sahuquillo, Francisco Martinez-Ricarte, Jordi Rodon, Ulrik Lassen, Christian Ottensmeier, Sjoerd H. van der Burg, Per Thor Straten, Hans Skovgaard Poulsen, Berta Ponsati, Hideho Okada, Hans-Georg Rammensee, Ugur Sahin, Harpreet Singh & Arie Admon. (2018) Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. Molecular & Cellular Proteomics 17:11, pages 2132-2145.
Crossref
Puja Sharma & Waldemar Debinski. (2018) Receptor-Targeted Glial Brain Tumor Therapies. International Journal of Molecular Sciences 19:11, pages 3326.
Crossref
Suvi Luoto, Ismaïl Hermelo, Elisa M. Vuorinen, Paavo Hannus, Juha Kesseli, Matti Nykter & Kirsi J. Granberg. (2018) Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma. Cancer Research 78:19, pages 5574-5585.
Crossref
Jessica Silva, Ana Miranda, João Sousa, Alberto Pais & Carla Vitorino. 2018. Biopharmaceuticals. Biopharmaceuticals.
Edouard Alphandéry. (2018) Glioblastoma Treatments: An Account of Recent Industrial Developments. Frontiers in Pharmacology 9.
Crossref
Sara Hanaei, Khashayar Afshari, Armin Hirbod-Mobarakeh, Bahram Mohajer, Delara Amir Dastmalchi & Nima Rezaei. (2018) Therapeutic efficacy of specific immunotherapy for glioma: a systematic review and meta-analysis. Reviews in the Neurosciences 29:4, pages 443-461.
Crossref
Hirokazu Sadahiro, Kyung-Don Kang, Justin T. Gibson, Mutsuko Minata, Hai Yu, Junfeng Shi, Rishi Chhipa, Zhihong Chen, Songjian Lu, Yannick Simoni, Takuya Furuta, Hemragul Sabit, Suojun Zhang, Soniya Bastola, Shinobu Yamaguchi, Hebaallah Alsheikh, Svetlana Komarova, Jun Wang, Sung-Hak Kim, Dolores Hambardzumyan, Xinghua Lu, Evan W. Newell, Biplab DasGupta, Mitsutoshi Nakada, L. James Lee, Burt Nabors, Lyse A. Norian & Ichiro Nakano. (2018) Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma. Cancer Research 78:11, pages 3002-3013.
Crossref
Jan Korbecki, Izabela Gutowska, Ireneusz Kojder, Dariusz Jeżewski, Marta Goschorska, Agnieszka Łukomska, Anna Lubkowska, Dariusz Chlubek & Irena Baranowska-Bosiacka. (2018) New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection. Oncotarget 9:6, pages 7219-7270.
Crossref
Mengxuan Chen, Weiyun Chai, Tengfei Song, Mingzhu Ma, Xiao-Yuan Lian & Zhizhen Zhang. (2018) Anti-glioma Natural Products Downregulating Tumor Glycolytic Enzymes from Marine Actinomycete Streptomyces sp. ZZ406. Scientific Reports 8:1.
Crossref
Fabliha Ahmed Chowdhury, Md Kamal Hossain, A. G. M. Mostofa, Maruf Mohammad Akbor & Muhammad Shahdaat Bin Sayeed. (2018) Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways. BioMed Research International 2018, pages 1-15.
Crossref
Santhosh A. Upadhyaya & Alberto Broniscer. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 557 568 .
Ana Miranda, María J Blanco-Prieto, João Sousa, Alberto Pais & Carla Vitorino. (2017) Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles. International Journal of Pharmaceutics 531:1, pages 389-410.
Crossref
Federico Mingozzi & Katherine A. High. (2017) Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape. Annual Review of Virology 4:1, pages 511-534.
Crossref
Analiz Rodriguez, Christine Brown & Behnam Badie. (2017) Chimeric antigen receptor T-cell therapy for glioblastoma. Translational Research 187, pages 93-102.
Crossref
Zui Xuan Xiao, Ruo Qiao Chen, Dian Xing Hu, Xiao Qiang Xie, Shang Bin Yu & Xiao Qian Chen. (2017) Identification of repaglinide as a therapeutic drug for glioblastoma multiforme. Biochemical and Biophysical Research Communications 488:1, pages 33-39.
Crossref
Wenling Wang, Tengfei Song, Weiyun Chai, Lu Chen, Lei Chen, Xiao-Yuan Lian & Zhizhen Zhang. (2017) Rare Polyene-polyol Macrolides from Mangrove-derived Streptomyces sp. ZQ4BG. Scientific Reports 7:1.
Crossref
Julia Y. Ljubimova, Tao Sun, Leila Mashouf, Alexander V. Ljubimov, Liron L. Israel, Vladimir A. Ljubimov, Vida Falahatian & Eggehard Holler. (2017) Covalent nano delivery systems for selective imaging and treatment of brain tumors. Advanced Drug Delivery Reviews 113, pages 177-200.
Crossref
Cuitian Chen, Ziqing Duan, Yan Yuan, Ruixiang Li, Liang Pang, Jianming Liang, Xinchun Xu & Jianxin Wang. (2017) Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB. ACS Applied Materials & Interfaces 9:7, pages 5864-5873.
Crossref
Emilie De Carli, Matthieu Delion & Audrey Rousseau. (2017) Immunothérapie des tumeurs cérébrales. Annales de Pathologie 37:1, pages 117-126.
Crossref
Frank Lieberman. (2017) Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials. F1000Research 6, pages 1892.
Crossref
Domenico Aquino, Andrea Gioppo, Gaetano Finocchiaro, Maria Grazia Bruzzone & Valeria Cuccarini. (2017) MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives. Journal of Immunology Research 2017, pages 1-16.
Crossref
Xiufang Zhang, Xuewei Ye, Weiyun Chai, Xiao-Yuan Lian & Zhizhen Zhang. (2016) New Metabolites and Bioactive Actinomycins from Marine-Derived Streptomyces sp. ZZ338. Marine Drugs 14:10, pages 181.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.